Genitourinary Cancers | Specialty

Molecularly Targeted Therapy and Immunotherapy: The Next Frontier in Metastatic Bladder Cancer

August 27th 2014

A major step toward improved tolerability of cisplatin-based therapy came in the early 2000s with the advent of the modern regimen of gemcitabine and cisplatin.

Dr. Parsons Discusses the Link Between Exercise and Bladder Cancer Risk

August 25th 2014

J. Kellogg Parsons, MD, associate professor of surgery (urology), University of California, San Diego, discusses modifiable lifestyle factors associated with bladder cancer.

Genes That Drive Clear-Cell RCC Discovered, Providing Research Clues

August 21st 2014

A genomic analysis of renal cell carcinoma (RCC) has uncovered new clues about the development, growth, and spread of the cancer.

In 2 Cancers, Robotic Versus Open Surgery is Explored

August 20th 2014

In recent studies, robotic-assisted surgery was explored as a treatment for both prostate and kidney cancers.

It's Not About the Organ

July 24th 2014

I am sure that those of you who attended the AUA meeting in Orlando were struck by the number of presentations on the use of biomarkers and their role in better risk stratification and management of the urologic oncology patient.

Dr. Hutson Discusses the Phase III ATLAS Study in RCC

July 18th 2014

Thomas E. Hutson, DO, PharmD, medical oncologist, Texas Oncology–Baylor Charles A. Sammons Cancer Center, discusses the rationale behind the ATLAS Study, a randomized double-blind phase III study of adjuvant axitinib versus placebo in subjects at high risk of recurrent renal cell carcinoma (RCC).

Immunotherapy Branches Out

July 18th 2014

Immunotherapy agents are delivering impressive results in a broad range of tumor types, reinforcing the excitement in research and investment circles for anticancer strategies that actively harness the immune system

Advanced Prostate Cancer Clinics Keep Urologists, Patients Together

July 10th 2014

When a patient develops advanced prostate cancer, that doesn't mean his urologist needs to bid him farewell.

Changing Treatment Landscape for RCC

June 25th 2014

Palliative Care for Patients With RCC

June 25th 2014

Role of TKIs in Oligometastatic RCC

June 25th 2014

PD-1 Inhibition in Renal Cell Carcinoma

June 25th 2014

Nivolumab in Renal Cell Carcinoma

June 25th 2014

Immunotherapy in Renal Cell Carcinoma

June 25th 2014

Second-Line Treatment Selection in RCC

June 25th 2014

First-line Therapy for Renal Cell Carcinoma

June 25th 2014

Treatment Considerations in Renal Cell Carcinoma

June 25th 2014

Treatment-Related Adverse Events in RCC

June 25th 2014

Alternative Dosing Schedules for Targeted Agents in RCC

June 25th 2014

Role of Cytoreductive Nephrectomy in mRCC

June 25th 2014